Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers

Conditions: Diabetic Foot Ulcer; Ulcer Foot; Diabetic Foot
Interventions: Device: Mirragen Wound Matrix; Device: Fibracol
Sponsors: ETS Wound Care, LLC; Professional Education and Research Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 9, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments